Rosa Noguera

6.8k total citations · 1 hit paper
126 papers, 3.4k citations indexed

About

Rosa Noguera is a scholar working on Neurology, Cancer Research and Oncology. According to data from OpenAlex, Rosa Noguera has authored 126 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Neurology, 46 papers in Cancer Research and 41 papers in Oncology. Recurrent topics in Rosa Noguera's work include Neuroblastoma Research and Treatments (75 papers), Cancer, Hypoxia, and Metabolism (42 papers) and Sarcoma Diagnosis and Treatment (24 papers). Rosa Noguera is often cited by papers focused on Neuroblastoma Research and Treatments (75 papers), Cancer, Hypoxia, and Metabolism (42 papers) and Sarcoma Diagnosis and Treatment (24 papers). Rosa Noguera collaborates with scholars based in Spain, Sweden and United States. Rosa Noguera's co-authors include Samuel Navarro, Antonio Llombart‐Bosch, Sven Påhlman, Alexander Pietras, Erik Fredlund, Adela Cañete, Rebeca Burgos‐Panadero, Antonio Pellı́n, Victoria Castel and Irene Tadeo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and PLoS ONE.

In The Last Decade

Rosa Noguera

125 papers receiving 3.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recruitment of HIF-1α and HIF-2α to common target genes is differentially regulated in neuroblastoma: HIF-2α promotes an aggressive phenotype

2006 594 citations Linda Holmquist Mengelbier, Erik Fredlund et al. Cancer Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rosa Noguera Spain	31	1.4k	1.4k	1.3k	848	677	126	3.4k
Karen Cichowski United States	35	840 0.6×	3.6k 2.5×	1.5k 1.2×	1.5k 1.7×	1.3k 1.9×	58	6.6k
Rani E. George United States	30	1.4k 0.9×	3.4k 2.4×	1.5k 1.1×	1.1k 1.3×	472 0.7×	55	4.9k
Béatrice Parfait France	30	629 0.4×	1.5k 1.1×	833 0.6×	295 0.3×	421 0.6×	83	3.3k
Nina N. Nupponen Finland	35	1.1k 0.8×	2.2k 1.5×	435 0.3×	999 1.2×	1.4k 2.1×	64	4.5k
Patrick N. Harter Germany	38	971 0.7×	1.9k 1.3×	476 0.4×	1.2k 1.4×	655 1.0×	181	4.8k
Elizabeth R. Lawlor United States	32	671 0.5×	1.9k 1.3×	307 0.2×	1.1k 1.3×	1.6k 2.4×	91	3.8k
F. Ann Hayes United States	38	683 0.5×	1.5k 1.1×	2.2k 1.7×	1.1k 1.2×	884 1.3×	64	4.4k
Melike Pekmezci United States	28	836 0.6×	1.3k 0.9×	556 0.4×	514 0.6×	744 1.1×	101	4.0k
Keishi Makino Japan	27	583 0.4×	1.5k 1.1×	608 0.5×	1.0k 1.2×	912 1.3×	95	4.2k
Natalia S. Pellegata Germany	33	716 0.5×	1.5k 1.1×	515 0.4×	1.8k 2.1×	290 0.4×	94	4.3k

Countries citing papers authored by Rosa Noguera

Since Specialization

Citations

This map shows the geographic impact of Rosa Noguera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa Noguera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa Noguera more than expected).

Fields of papers citing papers by Rosa Noguera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosa Noguera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa Noguera. The network helps show where Rosa Noguera may publish in the future.

Co-authorship network of co-authors of Rosa Noguera

This figure shows the co-authorship network connecting the top 25 collaborators of Rosa Noguera. A scholar is included among the top collaborators of Rosa Noguera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosa Noguera. Rosa Noguera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cordero, Teresa, Rogelio Monfort-Ortíz, Alfredo Perales, et al.. (2025). Multi-omics-based mapping of decidualization resistance in patients with a history of severe preeclampsia. Nature Medicine. 31(2). 502–513. 7 indexed citations

Westermann, Frank, et al.. (2024). Tackling ALT-positive neuroblastoma: is it time to redefine risk classification systems? A systematic review with IPD meta-analysis. Neoplasia. 60. 101106–101106. 1 indexed citations

López-Carrasco, Amparo, et al.. (2024). Characterization of Vitronectin Effect in 3D Ewing Sarcoma Models: A Digital Microscopic Analysis of Two Cell Lines. Cancers. 16(19). 3347–3347.

Carretero‐Barrio, Irene, Lara Pijuán, Fernando López‐Ríos, et al.. (2024). Concordance in the estimation of tumor percentage in non-small cell lung cancer using digital pathology. Scientific Reports. 14(1). 24163–24163. 1 indexed citations

López-Carrasco, Amparo, Nuria Estáñ, Raquel Portugal, et al.. (2024). Vitronectin Levels in the Plasma of Neuroblastoma Patients and Culture Media of 3D Models: A Prognostic Circulating Biomarker?. International Journal of Molecular Sciences. 25(16). 8733–8733. 2 indexed citations

Corallo, Diana, Carlo Zanon, Gian Paolo Tonini, et al.. (2021). Integrated CGH/WES Analyses Advance Understanding of Aggressive Neuroblastoma Evolution: A Case Study. Cells. 10(10). 2695–2695. 2 indexed citations

López-Carrasco, Amparo, Fernando Fariñas, Antonio J. Villatoro, et al.. (2021). Immunometabolism Modulation in Therapy. Biomedicines. 9(7). 798–798. 9 indexed citations

Lucantoni, Federico, et al.. (2020). Integrating the Tumor Microenvironment into Cancer Therapy. Cancers. 12(6). 1677–1677. 36 indexed citations

Carretero, Aitor, et al.. (2020). A three-dimensional bioprinted model to evaluate the effect of stiffness on neuroblastoma cell cluster dynamics and behavior. Scientific Reports. 10(1). 6370–6370. 45 indexed citations

10.

Burgos‐Panadero, Rebeca, et al.. (2020). Digital Image Analysis Applied to Tumor Cell Proliferation, Aggressiveness, and Migration-Related Protein Synthesis in Neuroblastoma 3D Models. International Journal of Molecular Sciences. 21(22). 8676–8676. 9 indexed citations

11.

Rodríguez‐Nogales, Carlos, Rosa Noguera, Patrick Couvreur, & María J. Blanco‐Prieto. (2019). Therapeutic Opportunities in Neuroblastoma Using Nanotechnology. Journal of Pharmacology and Experimental Therapeutics. 370(3). 625–635. 15 indexed citations

12.

Burgos‐Panadero, Rebeca, et al.. (2019). The topology of vitronectin: A complementary feature for neuroblastoma risk classification based on computer‐aided detection. International Journal of Cancer. 146(2). 553–565. 12 indexed citations

13.

Berbegall, Ana P., Eva Villamón, Marta Piqueras, et al.. (2015). Comparative genetic study of intratumoral heterogenous MYCN amplified neuroblastoma versus aggressive genetic profile neuroblastic tumors. Oncogene. 35(11). 1423–1432. 21 indexed citations

14.

Fernández-Carrobles, M. Milagro, Irene Tadeo, Gloria Bueno, et al.. (2013). TMA Vessel Segmentation Based on Color and Morphological Features: Application to Angiogenesis Research. The Scientific World JOURNAL. 2013(1). 263190–263190. 12 indexed citations

15.

Øra, Ingrid, Attila Frigyesi, Victoria Castel, et al.. (2011). Alternative lengthening of telomeres—An enhanced chromosomal instability in aggressive non‐MYCN amplified and telomere elongated neuroblastomas. Genes Chromosomes and Cancer. 50(4). 250–262. 29 indexed citations

16.

Pietras, Alexander, Loen M. Hansford, A. Johnsson, et al.. (2009). HIF-2α maintains an undifferentiated state in neural crest-like human neuroblastoma tumor-initiating cells. Proceedings of the National Academy of Sciences. 106(39). 16805–16810. 111 indexed citations

17.

Löfstedt, Tobias, Erik Fredlund, Rosa Noguera, et al.. (2009). HIF-1α induces MXI1 by alternate promoter usage in human neuroblastoma cells. Experimental Cell Research. 315(11). 1924–1936. 23 indexed citations

18.

Noguera, Rosa, Erik Fredlund, Marta Piqueras, et al.. (2009). HIF-1α and HIF-2α Are Differentially Regulated In vivo in Neuroblastoma: High HIF-1α Correlates Negatively to Advanced Clinical Stage and Tumor Vascularization. Clinical Cancer Research. 15(23). 7130–7136. 64 indexed citations

19.

Mengelbier, Linda Holmquist, Erik Fredlund, Tobias Löfstedt, et al.. (2006). Recruitment of HIF-1α and HIF-2α to common target genes is differentially regulated in neuroblastoma: HIF-2α promotes an aggressive phenotype. Cancer Cell. 10(5). 413–423. 594 indexed citations breakdown →

20.

Medina, Pascual, et al.. (1996). Reactivity of Human Deferential Artery to Constrictor and Dilator Substances. Journal of Andrology. 17(6). 733–739. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact